Latest Breaking News On - Immuneering corporation nasdaq - Page 1 : comparemela.com

Immuneering to Present at the Jefferies Global Healthcare Conference

Immuneering to Present at the Jefferies Global Healthcare Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesMallory moralesBen zeskindLaurence wattsGina nugentCompany presentationImmuneering corporationEvents presentations immuneering corporationMarriott marquisImmuneering corporation nasdaqJefferies global healthcare conferenceNew york cityChief executive officerChief accounting officer

Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates

Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBen zeskindGina nugentLaurence wattsThomasj schallDrug administrationExchange commissionImmuneering corporationImmuneering corporation nasdaqDevelopment rd expensesCompany phaseAmerican association for cancer researchReports first quarterProvides businessPositive topline results

Immuneering Recognizes Melanoma Awareness Month

- Two clinical stage product candidates in development for the treatment of melanoma - - RAS mutant melanoma represents one of five arms in the company’s ongoing Phase 2a clinical study of.

United kingdomBrett hallGina nugentLaurence wattsExchange commissionImmuneering corporationMelanoma research allianceImmuneering corporation nasdaqMelanoma awareness monthAwareness monthJoan levyChief science officerMelanoma researchChief scientific officerDeep cyclic inhibitionDeep cyclic inhibitor

IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models

- Preclinical data presented at AACR demonstrate that combining IMM-1-104 with chemotherapies used in the treatment of first-line pancreatic cancer yielded deeper and more durable tumor growth.

United kingdomUnited statesLaurence wattsGina nugentBrett hallAmerican association for cancer researchImmuneering corporationImmuneering corporation nasdaqExchange commissionAmerican associationCancer researchAnnual meetingChief scientific officerDeep cyclic inhibitionDeep cyclic inhibitorPrivate securities litigation reform act

Immuneering Corporation (IMRX) Says IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models

Immuneering Corporation (IMRX) Says IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrett hallAmerican association for cancer researchImmuneering corporationImmuneering corporation nasdaqAmerican associationCancer researchAnnual meetingChief scientific officer